Subjects had to be on a maximally tolerated dose of ACE/ARB for @ months ; stable other antihypertensive doses for @ months ; stable diuretic dose for @ weeks , and BP @/@ mm Hg ; or enter a Pharmaco-Stabilization Phase ( PSP ) .